Publication | Closed Access

Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro

GlomerulonephritisAutoimmune DiseaseAutoantibody ProductionLupusAnti-c1q AutoantibodiesLupus NephritisImmunologyPathologyAutoimmunityAutoantibodiesInflammatory Rheumatic DiseaseImmunologic DiseaseImmunosuppressionApoptotic CellsImmunotherapyMedicineRheumatoid Arthritis